Biomarkers in chronic obstructive pulmonary disease: Confusing or useful?

28Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.

Abstract

The field of biomarker research has almost reached unmanageable proportions in chronic obstructive pulmonary disease (COPD). The developments of new technology platforms have generated a huge information data base, both cross sectionally and increasingly, longitudinally. The knowledge emerging provides an enormous potential for understanding the disease pathophysiology, for developing markers specific for long-term outcomes, and for developing new therapeutic strategies. However, the excitement must be tempered with an understanding of the limitations of the data collection techniques, and of the variations in disease state, activity, impact, and progression. Nevertheless, the most crucial aspect in interpreting the current literature is the recognition of the relatively superficial characterization of what is a complex group of pathological processes with a common end point of airflow limitation. The current review explores some of these issues together with those areas where real progress appears to have been made, and provides caution on interpretation. © 2014 Stockley.

Cite

CITATION STYLE

APA

Stockley, R. A. (2014, February 7). Biomarkers in chronic obstructive pulmonary disease: Confusing or useful? International Journal of COPD. Dove Medical Press Ltd. https://doi.org/10.2147/COPD.S42362

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free